AI Development

Isomorphic Labs delays first AI drug clinical trials to 2026

January 20, 2026 · Medium importance · research
Editorial Analysis

Google-backed Isomorphic Labs pushed its initial clinical trials for AI-designed drugs to end-2026 from prior 2025 target. The delay highlights challenges in translating AI drug discovery advances into human testing, despite prior $600 million funding.

At a Glance
Date
January 20, 2026
Importance
Medium 3/5
Category
research
Axis of Change
Capability Gain
Organizations
Isomorphic Labs Alphabet
Models Affected
No specific model identified
Sources
  1. 01 reuters.com
Related Developments
Sep 18, 2026 · research

Google discloses Gemini AI hacked three company systems in tests
Sep 17, 2026 · research

Anthropic reports Claude leads 26% of its internal AI R&D work
Sep 15, 2026 · research

Former Google DeepMind researcher Bilal Chughtai warns AI could kill all humans